Examiner Aggarwal Sahil C

1623-AGGARWAL-SAHIL-C

Employment Information

Art Unit:1623 — Drug, bio-affecting and body treating compositions
Group:1620 — Biomedicinal Chemistry
Classes: 514 — Drug, bio-affecting and body treating compositions
536 — Organic compounds -- part of the class 532-570 series
548 — Organic compounds -- part of the class 532-570 series
549 — Organic compounds -- part of the class 532-570 series
558 — Organic compounds -- part of the class 532-570 series
556 — Organic compounds -- part of the class 532-570 series
Phone:(571) 272-7755
Email:None
Location:None

Grant Rate and Difficulty Ranking

99
3-Year Grant rate: 0% over 30 cases
Difficulty: Extremely Hard
Difficulty Percentile: 99th

With Examiner Aggarwal, you have a 0% chance of getting an issued patent by 3 years after the first office action. Examiner Aggarwal is an extremely hard examiner and in the 99th percentile across all examiners (with 100th percentile most difficult).

Grant Rate

Grant Rate Timeline

Below is the grant rate timeline for Examiner Aggarwal, where the timeline is relative to the date of the first office action. The three-year grant rate is the percentage of applications granted at three years after the first office action.

Comparison with Art Unit 1623

Examiner Aggarwal's grant rate is lower than that of Art Unit 1623 and lower than that of the USPTO.

Average Office Actions Per Grant
Examiner Aggarwal 0.0
Art Unit 1623 1.5

Interview Benefit

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Recent Dispositions

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeals Statistics

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Appeal History

Purchase Subscription

Subscribe to Premium Examiner Statistics for unlimited access to our examiner statistics.

Disclaimer: We do not provide any guarantees as to the accuracy of the statistics presented above and under
no circumstances will we be liable for any outcome resulting from your reliance on the above statistics.

Loading...